Quantcast

Latest Bristol-Myers Squibb Stories

2014-09-29 23:03:24

In May, the website for mesothelioma patients and their families reported on the first mesothelioma patient accepted into a U.K. clinical trial of the drug, which was recently approved by the FDA for use in treating advanced melanoma patients. New York, NY (PRWEB) September 29, 2014 MesotheliomaHelp.org is calling attention today to the U.S. Food and Drug Administration’s accelerated approval of Keytruda (pembrolizumab; MK-3475) for the treatment of patients with advanced or surgically...

2014-09-25 12:29:32

DUBLIN, Sept. 25, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered look at the pharmaceutical industry,...

2014-09-24 16:25:59

GENEVA, September 24, 2014 /PRNewswire/ -- AF is the most common type of heart arrhythmia in the world, responsible for 15 - 20 per cent of strokes which affect the brain The World Heart Federation (WHF) is delighted to announce a charitable donation from the pharmaceutical companies Bristol-Myers Squibb and Pfizer. The donation will support a program aimed at engaging patients with atrial fibrillation (AF) and their carers, along with...

2014-08-29 08:23:13

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, August 29, 2014 /PRNewswire/ -- Today, Analysts Review released its research reports regarding Mallinckrodt plc (NYSE: MNK), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Kite Pharma, Inc. (NASDAQ: KITE), Bristol-Myers Squibb Company (NYSE: BMY) and Arrowhead Research Corp. (NASDAQ: ARWR). Private wealth members receive these notes ahead of publication. To reserve complementary...

2014-08-28 12:30:01

Introduction of Extended RAS Testing and Recent Clinical Trial Data Will Affect How Physicians Treat Colorectal Cancer Patients, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 28, 2014 /PRNewswire/ -- Decision Resources Group finds that the market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. The biosimilar erosion of...

2014-08-28 12:28:55

CHICAGO, Aug. 28, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the InterMune (Nasdaq:ITMN-Free Report), Kite Pharma (NASDAQ:KITE-Free Report), Amicus (Nasdaq:FOLD-Free Report), Celgene (Nasdaq:CELG-Free Report) and Bristol-Myers Squibb (NYSE:BMY-Free Report)....

2014-08-15 12:25:07

ATLANTA, Aug. 15, 2014 /PRNewswire/ -- Avion Pharmaceuticals, LLC, announces the signing of a commercial license agreement with Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) for the development and commercialization of four Captisol-enabled programs. Under the terms of the agreement, Ligand is entitled to receive an up-front payment, and is eligible to receive revenue from Captisol® material sales, potential milestone payments, and royalties on future net sales of the products...

2014-08-12 16:27:31

DUBLIN, Aug. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Biological drugs are typically derived from living cells and are used in the treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders....

2014-08-07 12:28:07

NUSSLOCH, Germany, August 7, 2014 /PRNewswire/ -- - Leica Biosystems announces a collaboration with Bristol-Myers Squibb to develop companion diagnostic tests in support of targeted therapeutics - Leica Biosystems will develop fully automated tissue-based companion diagnostic tests to run on the BOND(TM) automated advanced staining systems Leica Biosystems, today announced an agreement with Bristol-Myers Squibb Company (NYSE:...

2014-07-31 16:27:33

OTTAWA, July 31, 2014 /CNW/ - Health Canada today released the July 2014 issue of the Canadian Adverse Reaction Newsletter (CARN). This issue includes an article on the anti-cancer drug cisplatin and the risk of blockage of the aorta, the body's main artery. It also includes an article on hydroxychloroquine, a drug used for rheumatoid arthritis, lupus, and malaria, and the risk of developing low blood sugar; and a case presentation on a suspected interaction between efavirenz, an...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related